Skip to content
lifestyle.gamezon.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Fangzhou Inc.
Fangzhou Releases 2026 Interim Report, Deepening “AI + Chronic Care” as a Lifetime Health Service Partner
September 25, 2026
Fangzhou’s AI-Powered Chronic Care Model Named to Fortune China’s Best Designs 2026
September 3, 2026
Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
August 27, 2026
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
July 19, 2026
Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care
July 9, 2026
Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
May 14, 2026
Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference
May 13, 2026
Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026
April 27, 2026
Fangzhou Inc. Appoints Healthcare Industry Veteran Wang Haijiao as Chief Executive Officer Following a Year of Record Growth and Profitability
March 26, 2026
Fangzhou Reports Robust 2025 Financial Results, Boosted by AI Chronic Care Strategy
March 19, 2026